Breitbart News reported on Monday that the National Institute of Health has funded its acquisition of a company that has a proven ability to produce “illumination films.”

The company is the company that produces the highly-visible “illuminations” that are used by many industries to show what is being filmed, according to The Wall Street Journal.

It has a patent on the technology and is also a key player in the development of a patent-pending technology that is able to create the images.

Illumina was created by former Harvard Computer Science Professor Dr. Arun Bhattacharya.

It is a software development company that works on the software used in the most popular camera cameras in the world, including the Sony A7, Sony A8, Sony E, Sony RX100, Nikon D3200 and Nikon D40.

The company, which has been developing “illustrative” cameras since the 1980s, had an estimated value of $7.7 billion.

It was acquired by the NIH for $1 billion in 2017.

While Illumina has a number of patents on the product, its technology appears to have a long way to go before it can be commercially viable.

The National Institutes on Monday approved the $1 million investment. 

Illuminas technology is able in a “single step” to produce a variety of “illustration” images.

These images, which are created using a camera, are then combined to produce an “illument,” or digital image, which is then combined with the original image to create a complete image.

The “illuminati” image is shown above.

Illuminas technology is already available in the form of a smartphone app called “Illuminatr.”

It can be used to create multiple images in a single tap.

The app can also be used in conjunction with another app, called “Bravo,” which uses Illumina technology to create an animated gif.

This new acquisition, however, has raised concerns among some critics who have been concerned about the technology’s ability to create “illusions” that can be displayed on a smartphone screen.

A spokesperson for the NIH told The Wall St. Journal that “Illumination has the potential to dramatically increase consumer confidence in the technology, and it will enhance the NIH’s ability in delivering health care to more people.”

The National Institute for Standards and Technology, which oversees the National Science Foundation, is not involved in this acquisition, according the spokesperson.

The spokesperson said that the NIH will work with the company “to support its continued growth.”